Profile data is unavailable for this security.
About the company
Titan Pharmaceuticals, Inc. is a pharmaceutical company. The Company is focused on developing therapeutics utilizing the proprietary long-term drug delivery platform, ProNeura, for the treatment of select chronic diseases. ProNeura offers continuous drug delivery and consists of a small, semi-rigid, flexible implant made from a mixture of ethylene-vinyl acetate (EVA) and a drug substance. The resulting product is a solid matrix implant that is placed subdermally, normally in the inside part of the upper arm, in a brief procedure using a local anesthetic and is removed in a similar manner at the end of the treatment period. Its product pipeline includes Kappa Opioid Receptor Agonist (TP-2021) Implant, which is used for the treatment of moderate-to-severe chronic pruritus. Its product development programs are in non-clinical stages of development.
- Revenue in USD (TTM)4.00k
- Net income in USD-5.46m
- Incorporated1992
- Employees4.00
- LocationTitan Pharmaceuticals IncSUITE 505, 400 OYSTER POINT BLVDSAN FRANCISCO 94080United StatesUSA
- Phone+1 (415) 244-4990
- Fax+1 (650) 244-4956
- Websitehttps://www.titanpharm.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Onconetix Inc | 1.46m | -53.12m | 3.52m | 12.00 | -- | -- | -- | 2.40 | -2.62 | -2.62 | 0.0723 | 1.27 | 0.0328 | 3.45 | 5.30 | 121,979.20 | -119.09 | -- | -215.11 | -- | -57.21 | -- | -3,629.24 | -- | 0.091 | -11.87 | 0.2984 | -- | -- | -- | -176.78 | -- | -- | -- |
| Shuttle Pharmaceuticals Holdings Inc | 0.00 | -7.20m | 3.70m | 8.00 | -- | 0.5453 | -- | -- | -10.29 | -10.29 | 0.00 | 3.04 | 0.00 | -- | -- | 0.00 | -123.53 | -- | -147.27 | -- | -- | -- | -- | -- | -- | -4.32 | 0.5076 | -- | -- | -- | -112.71 | -- | -- | -- |
| China Pharma Holdings Inc | 6.25m | -4.40m | 3.88m | 231.00 | -- | 0.5233 | -- | 0.6205 | -0.6254 | -0.6254 | 0.6379 | 0.4317 | 0.417 | 2.34 | 23.57 | 27,047.32 | -29.39 | -29.66 | -59.89 | -55.25 | -25.89 | 6.47 | -70.48 | -73.09 | 0.2449 | -21.22 | 0.277 | -- | -13.48 | -10.68 | 22.50 | -- | -25.78 | -- |
| Tian'an Pharmaceutical Co Ltd | 10.65m | 3.14m | 4.24m | -- | 0.0236 | 0.0051 | 1.16 | 0.3981 | 0.2246 | 0.2246 | 0.7611 | 1.03 | -- | -- | -- | -- | -- | -- | -- | -- | 68.54 | -- | 29.51 | -- | 13.36 | 25.66 | 0.00 | -- | 50.51 | -- | 106.71 | -- | -- | -- |
| Sonoma Pharmaceuticals Inc | 12.70m | -4.56m | 4.41m | 172.00 | -- | 0.8213 | -- | 0.3473 | -10.07 | -10.07 | 20.98 | 5.24 | 0.859 | 2.91 | 4.47 | 73,831.40 | -30.85 | -29.36 | -41.88 | -40.65 | 38.17 | 38.00 | -35.91 | -30.93 | 2.47 | -- | 0.0394 | -- | -4.05 | -7.66 | 6.13 | -- | -29.84 | -- |
| Stemtech Corp | 5.37m | -5.11m | 4.44m | 45.00 | -- | -- | -- | 0.8276 | -0.0518 | -0.0518 | 0.0529 | -0.0359 | 1.33 | 8.39 | 42.31 | -- | -126.26 | -- | -- | -- | 77.87 | -- | -95.16 | -- | 0.065 | -2.59 | -- | -- | 7.94 | -- | 36.45 | -- | -- | -- |
| Silo Pharma Inc | 72.12k | -3.45m | 4.57m | 3.00 | -- | 0.637 | -- | 63.42 | -1.16 | -1.18 | 0.0242 | 1.60 | 0.0079 | -- | -- | 24,040.00 | -37.69 | -24.90 | -43.50 | -26.39 | 91.90 | 82.79 | -4,777.02 | -2,757.85 | -- | -- | 0.00 | -- | 0.00 | -- | 7.07 | -- | -- | -- |
| Processa Pharmaceuticals Inc | 0.00 | -10.22m | 4.62m | 13.00 | -- | 0.6763 | -- | -- | -5.36 | -5.36 | 0.00 | 2.10 | 0.00 | -- | -- | 0.00 | -115.58 | -84.35 | -133.48 | -90.03 | -- | -- | -- | -- | -- | -- | 0.0016 | -- | -- | -- | 59.45 | -- | -34.05 | -- |
| GT Biopharma Inc | 0.00 | -11.35m | 4.87m | 2.00 | -- | 0.8845 | -- | -- | -7.72 | -7.72 | 0.00 | 2.47 | 0.00 | -- | -- | 0.00 | -82.84 | -205.36 | -120.73 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 63.62 | -- | -- | -- |
| CYANOTECH CORP | 23.82m | -5.10m | 4.87m | 77.00 | -- | 0.4563 | -- | 0.2045 | -0.7549 | -0.7549 | 3.56 | 1.53 | 0.8895 | 2.05 | 12.12 | 309,389.60 | -19.04 | -3.46 | -29.60 | -4.46 | 24.72 | 34.54 | -21.41 | -3.58 | 0.3354 | -6.61 | 0.377 | -- | -0.4616 | -5.24 | -53.11 | -- | -6.42 | -- |
| AgriFORCE Growing Systems Ltd | 57.60k | -15.05m | 4.91m | 7.00 | -- | 0.3873 | -- | 85.17 | -5.81 | -5.81 | 0.0037 | 0.1343 | 0.0034 | -- | 1.21 | 8,228.57 | -88.79 | -78.95 | -124.14 | -109.86 | 17.86 | -- | -26,121.49 | -243,182.50 | 1.24 | -1.28 | 0.0789 | -- | -- | -- | 8.85 | -- | 48.61 | -- |
| Titan Pharmaceuticals Inc | 4.00k | -5.46m | 5.17m | 4.00 | -- | 1.30 | -- | 1,293.64 | -6.59 | -6.59 | 0.0049 | 4.37 | 0.0016 | -- | 0.1702 | 1,000.00 | -211.58 | -96.80 | -368.99 | -156.65 | -- | -- | -136,525.00 | -406.26 | -- | -309.96 | 0.00 | -- | -66.97 | -51.16 | 45.43 | -- | -65.61 | -- |
| Sonnet Biotherapeutics Holdings Inc | 55.89k | -7.99m | 5.20m | 12.00 | -- | 1.99 | -- | 93.08 | -3.02 | -3.02 | 0.0144 | 0.5017 | 0.0071 | -- | 0.0881 | 4,657.50 | -100.88 | -- | -255.30 | -- | -- | -- | -14,287.67 | -- | -- | -331.07 | 0.00 | -- | -57.76 | -- | 36.64 | -- | -- | -- |
| Cannapharmarx Inc | 25.84k | 627.24k | 5.83m | 21.00 | -- | -- | 8.39 | 225.62 | -0.0061 | -0.0061 | 0.00006 | -0.0254 | 0.003 | -- | 0.1654 | 1,230.48 | 7.36 | -131.06 | -- | -- | -1,692.76 | -- | 2,427.40 | -- | 0.0123 | -0.2483 | -- | -- | -- | -- | 143.24 | -- | -- | -- |
| Integrated BioPharma, Inc. | 50.57m | -116.00k | 6.77m | 141.00 | -- | 0.3578 | 31.92 | 0.1338 | -0.0041 | -0.0041 | 1.67 | 0.6283 | 1.88 | 4.45 | 10.76 | 358,617.00 | -0.431 | 15.54 | -0.5698 | 28.00 | 7.09 | 12.09 | -0.2294 | 6.45 | 1.02 | -9.00 | 0.001 | -- | -9.91 | 3.00 | -100.42 | -- | -14.03 | -- |
Data as of Sep 19 2024. Currency figures normalised to Titan Pharmaceuticals Inc's reporting currency: US Dollar USD
3.52%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Truist Bank (Private Banking)as of 30 Jun 2024 | 31.25k | 3.42% |
| Tower Research Capital LLCas of 30 Jun 2024 | 717.00 | 0.08% |
| MCF Advisors LLCas of 30 Jun 2024 | 165.00 | 0.02% |
| Group One Trading LPas of 30 Jun 2024 | 12.00 | 0.00% |
| BofA Securities, Inc.as of 30 Jun 2024 | 11.00 | 0.00% |
| Osaic Wealth, Inc. (Investment Management)as of 30 Jun 2024 | 7.00 | 0.00% |
| Bank of America, NA (Private Banking)as of 30 Jun 2024 | 6.00 | 0.00% |
| American Portfolios Advisors, Inc.as of 30 Jun 2024 | 3.00 | 0.00% |
| Morgan Stanley Smith Barney LLC (Investment Management)as of 30 Jun 2024 | 3.00 | 0.00% |
| Global Wealth Strategies & Associates LLCas of 30 Jun 2024 | 2.00 | 0.00% |
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
